3 Marijuana Stocks That Could Fall 47% (or More), According to Wall StreetPosted by On

Medical cannabis logo

After a nearly two-year hiatus, marijuana stocks are again one of the hottest investments on Wall Street. In the U.S., 36 states have waved the green flag on medical marijuana, and 15 of them also allow adult-use consumption and/or the retail sale of recreational weed. Meanwhile, Canada opened its doors to recreational cannabis sales on Oct. 17, 2018.

Following a slow start, monthly pot sales in our neighbor to the north are hitting all-time highs. North America represents a potential $75 billion opportunity for the cannabis industry by the end of this decade.

But not all pot stocks have Wall Street professionals convinced of their success. Three marijuana stocks are forecast to lose at least 47% of their value, as measured by Wall Street’s one-year consensus price targets.

A smoldering cannabis bud that's beginning to turn black.

Image source: Getty Images.

HEXO: Implied downside of 47%

As you’re about to see, Wall Street investment banks aren’t thrilled about Canadian pot stocks. It all begins with Quebec-based HEXO (NYSE:HEXO), which would need to fall by 47% to reach Wall Street’s one-year price target.

I’ll be the first to admit that HEXO fooled me big time. It signed what’s still the largest wholesale agreement to date in 2018 — a 200,000…

Original Author Link click here to read complete story..

After a nearly two-year hiatus, marijuana stocks are again one of the hottest investments on Wall Street. In the U.S., 36 states have waved the green flag on medical marijuana, and 15 of them also allow adult-use consumption and/or the retail sale of recreational weed. Meanwhile, Canada opened its doors to recreational cannabis sales on Oct. 17, 2018.

Following a slow start, monthly pot sales in our neighbor to the north are hitting all-time highs. North America represents a potential $75 billion opportunity for the cannabis industry by the end of this decade.

But not all pot stocks have Wall Street professionals convinced of their success. Three marijuana stocks are forecast to lose at least 47% of their value, as measured by Wall Street’s one-year consensus price targets.

A smoldering cannabis bud that's beginning to turn black.

Image source: Getty Images.

HEXO: Implied downside of 47%

As you’re about to see, Wall Street investment banks aren’t thrilled about Canadian pot stocks. It all begins with Quebec-based HEXO (NYSE:HEXO), which would need to fall by 47% to reach Wall Street’s one-year price target.

I’ll be the first to admit that HEXO fooled me big time. It signed what’s still the largest wholesale agreement to date in 2018 — a 200,000…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.